ClassID:

20014

A61K9/0004 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Galenical forms characterised by the drug release technique; Application systems commanded by energy Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Recent Application in this class:
#301
20170252447
2017-09-07

INFUSABLE SOLUTION FOR LOCAL TREATMENT OF BLOOD VESSELS AND VASCULAR GRAFTS AND METHODS OF USING SUCH A SOLUTION

#302
20170252334
2017-09-07

Ataxia therapeutic compositions and methods

#303
20170246267
2017-08-31

CHOLINERGIC ANTAGONISM AS AN ADJUNCT TO CANCER THERAPY

#304
20170231902
2017-08-17

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#305
20170224970
2017-08-10

Implants for localized drug delivery and methods of use thereof

#306
20170216236
2017-08-03

Controlled release dosage form

#307
20170202786
2017-07-20

NOVEL PULSATILE DRUG DELIVERY SYSTEM

#308
20170181964
2017-06-29

TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR

#309
20170165224
2017-06-15

Compositions for improving safety of pharmacological formulations

#310
20170151229
2017-06-01

Methods of manufacturing oral formulations

#311
20170151185
2017-06-01

AMANTADINE COMPOSITIONS AND METHODS OF USE

#312
20170119855
2017-05-04

STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES

#313
20170119854
2017-05-04

HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF

#314
20170119741
2017-05-04

Macrocyclic lactone compounds and methods for their use

#315
20170119740
2017-05-04

Methods for treating cancer by activation of BMP signaling

#316
20170105927
2017-04-20

Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid

#317
20170100350
2017-04-13

EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE

#318
20170087152
2017-03-30

Methods of providing analgesia

#319
20170080017
2017-03-23

Treatment and prevention of learning and memory disorders

#320
20170080016
2017-03-23

Compositions and methods for treatment of osteoporosis and other indications

#321
20170079906
2017-03-23

DEVICES, FORMULATIONS, AND METHODS FOR DELIVERY OF MULTIPLE BENEFICIAL AGENTS

#322
20170072022
2017-03-16

Osmotic delivery device comprising an insulinotropic peptide and uses thereof

#323
20170071923
2017-03-16

Sustained release oral dosage form containing dalfampridine

#324
20170056634
2017-03-02

Controlled release nanoparticulate matter delivery system

#325
20170056319
2017-03-02

Positive pressure capsules and method of manufacturing the same

#326
20170049774
2017-02-23

SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB

#327
20170043143
2017-02-16

Implantable drug delivery device

#328
20170035777
2017-02-09

Long-acting polymeric delivery systems

#329
20170028127
2017-02-02

Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier

#330
20170027863
2017-02-02

Oral controlled release pharmaceutical compositions of Bepotastine

#331
20160374937
2016-12-29

Drug condensation aerosols and kits

#332
20160374936
2016-12-29

MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT

#333
20160367550
2016-12-22

Naloxone single agent and multilayer tablets

#334
20160361420
2016-12-15

PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE

#335
20160354305
2016-12-08

Rapid establishment and/or termination of substantial steady-state drug delivery

#336
20160324966
2016-11-10

Polymeric nanocarriers with light-triggered release mechanism

#337
20160324845
2016-11-10

NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN

#338
20160317505
2016-11-03

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

#339
20160310419
2016-10-27

Controlled release dosage form for once daily administration of dimethyl fumarate

#340
20160310408
2016-10-27

Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same

#341
20160279399
2016-09-29

OSMOTIC DRUG DELIVERY DEVICES, KITS, AND METHODS

#342
20160263058
2016-09-15

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#343
20160263057
2016-09-15

AMANTADINE COMPOSITIONS AND METHODS OF USE

#344
20160263055
2016-09-15

AMANTADINE COMPOSITIONS AND METHODS OF USE

#345
20160263054
2016-09-15

AMANTADINE COMPOSITIONS AND METHODS OF USE

#346
20160263053
2016-09-15

AMANTADINE COMPOSITIONS AND METHODS OF USE

#347
20160263052
2016-09-15

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#348
20160263043
2016-09-15

Controlled release dosage form

#349
20160263042
2016-09-15

Osmotic drug delivery system

#350
20160256514
2016-09-08

METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING

#351
20160243072
2016-08-25

Controlled release dosage form

#352
20160243067
2016-08-25

Controlled release dosage form

#353
20160199544
2016-07-14

Multi-unit drug delivery devices and methods

#354
20160193456
2016-07-07

Methods for intravesical drug delivery and methods and systems for loading devices with drug tablets

#355
20160177931
2016-06-23

Electroosmotic pump and fluid pumping system including the same

#356
20160166564
2016-06-16

Nicotine salt with meta-salicylic acid

#357
20160158224
2016-06-09

Controlled release hydrocodone formulations

#358
20160158223
2016-06-09

Controlled release hydrocodone formulations

#359
20160158145
2016-06-09

Container

#360
20160151361
2016-06-02

Controlled release hydrocodone formulations

#361
20160151292
2016-06-02

Controlled release hydrocodone formulations

#362
20160151288
2016-06-02

Controlled release hydrocodone formulations

#363
20160136178
2016-05-19

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

#364
20160106748
2016-04-21

Pharmaceutical gastro-retentive solid oral dosage form of nilotinib

#365
20160095862
2016-04-07

Methods and devices for renal nerve blocking

#366
20160095820
2016-04-07

METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS

#367
20160058788
2016-03-03

Multiple PPI dosage form

#368
20160058725
2016-03-03

Topical Formulations and Methods for Drug Delivery

#369
20160045542
2016-02-18

Compositions and methods for treatment of osteoporosis and other indications

#370
20160045540
2016-02-18

Treatment and prevention of learning and memory disorders

#371
20160038522
2016-02-11

Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis

#372
20160030583
2016-02-04

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

#373
20160030471
2016-02-04

HYPERSATURATED GAS IN LIQUID

#374
20160030419
2016-02-04

Oxycodone formulations

#375
20160030355
2016-02-04

Osmotic drug delivery system

#376
20160025083
2016-01-28

Electro-osmotic pump using reversible electrode reaction and fluid pumping system using same

#377
20160022976
2016-01-28

Method and composition for hyperthermally treating cells

#378
20160022582
2016-01-28

HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF

#379
20160015628
2016-01-21

Heterocyclic compounds and their uses

#380
20160008335
2016-01-14

Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters

#381
20160008271
2016-01-14

Drug delivery devices and methods for drug delivery

#382
20150366817
2015-12-24

Delayed-release formulations, methods of making and use thereof

#383
20150352089
2015-12-10

MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE

#384
20150320675
2015-11-12

Modified Release Osmotic Pump for PH-Responsive Drug Delivery

#385
20150306097
2015-10-29

Hydrazaline hydrochloride pellets and method of preparation

#386
20150290291
2015-10-15

Solvent/polymer solutions as suspension vehicles

#387
20150272870
2015-10-01

INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF

#388
20150272869
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof

#389
20150272868
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof

#390
20150272867
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof

#391
20150272866
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof

#392
20150265537
2015-09-24

Controlled release hydrocodone formulations

#393
20150258195
2015-09-17

POLYMERIC NANOCARRIERS WITH LIGHT-TRIGGERED RELEASE MECHANISM

#394
20150258090
2015-09-17

Controlled release hydrocodone formulations

#395
20150258089
2015-09-17

Controlled release hydrocodone formulations

#396
20150258018
2015-09-17

Microfabricated nanopore device for sustained release of therapeutic agent

#397
20150258017
2015-09-17

Microfabricated nanopore device for sustained release of therapeutic agent

#398
20150258016
2015-09-17

OSMOTIC DELIVERY DEVICE COMPRISING AN INSULINOTROPIC PEPTIDE AND USES THEREOF

#399
20150245992
2015-09-03

PHARMACEUTIC OSMOTIC PUMP PREPARATION

#400
20150238420
2015-08-27

Naloxone mono preparation and multilayer tablet

#401
20150238418
2015-08-27

Controlled release hydrocodone formulations

#402
20150231256
2015-08-20

STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES

#403
20150231062
2015-08-20

Two-piece, internal-channel osmotic delivery system flow modulator

#404
20150209277
2015-07-30

IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY

#405
20150202147
2015-07-23

Modified release formulations of a bupropion salt

#406
20150190342
2015-07-09

Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation process and applications

#407
20150174318
2015-06-25

Microfabricated nanopore device for sustained release of therapeutic agent

#408
20150157579
2015-06-11

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#409
20150157558
2015-06-11

METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM

#410
20150151267
2015-06-04

Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation method thereof and uses of the same

#411
20150140095
2015-05-21

Once-a-day oxycodone formulations

#412
20150126928
2015-05-07

Drug delivery device

#413
20150126612
2015-05-07

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#414
20150126605
2015-05-07

Composition and method for treating neurological disease

#415
20150111818
2015-04-23

Devices, formulations, and methods for delivery of multiple beneficial agents

#416
20150105751
2015-04-16

Multiple reservoir drug delivery device and methods

#417
20150105610
2015-04-16

Multiple reservoir drug delivery device and methods

#418
20150086629
2015-03-26

Stabilized formulations of CNS compounds

#419
20150086608
2015-03-26

MATRIX AND DEVICE AND USE THEREOF FOR OPTICALLY-CONTROLLED RELEASE OF CHEMICALS

#420
20150064264
2015-03-05

Pharmaceutical dosage forms comprising a low-solubility drug and a polymer

#421
20150045447
2015-02-12

AMANTADINE COMPOSITIONS AND METHODS OF USE

#422
20150010660
2015-01-08

Compositions and methods for treatment of osteoporosis and other indications

#423
20150010658
2015-01-08

Treatment and prevention of learning and memory disorders

#424
20140378900
2014-12-25

Osmotic delivery systems and piston assemblies for use therein

#425
20140377332
2014-12-25

Nanoshells on polymers

#426
20140364475
2014-12-11

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING

#427
20140358122
2014-12-04

Drug coating layer

#428
20140356425
2014-12-04

Composition and method for treating neurological disease

#429
20140350001
2014-11-27

Pharmaceutical formulations of potassium ATP channel openers and uses thereof

#430
20140348777
2014-11-27

Polysorbitol-based osmotically active transporter and gene therapy using same

#431
20140343164
2014-11-20

Composition and method for treating neurological disease

#432
20140343163
2014-11-20

Composition and method for treating neurological disease

#433
20140343154
2014-11-20

Composition and method for treating neurological disease

#434
20140322296
2014-10-30

PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM

#435
20140309598
2014-10-16

OSMOTICALLY ACTIVE VAGINAL DELIVERY SYSTEM

#436
20140302141
2014-10-09

Triple combination release multi-layered tablet

#437
20140276329
2014-09-18

Trans-sclera portal for delivery of therapeutic agents

#438
20140271842
2014-09-18

Tofacitinib oral sustained release dosage forms

#439
20140199394
2014-07-17

Controlled release hydrocodone

#440
20140135743
2014-05-15

System and method for correction of intracerebral chemical imbalances

#441
20140134239
2014-05-15

Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents

#442
20140120164
2014-05-01

Polymer release system

#443
20140088346
2014-03-27

Multiple reservoir drug delivery device and methods

#444
20140088345
2014-03-27

SINGLE CHANNEL, MULTIPLE DRUG DELIVERY DEVICE AND METHODS

#445
20140086972
2014-03-27

Microfabricated nanopore device for sustained release of therapeutic agent

#446
20140079754
2014-03-20

Microfabricated nanopore device for sustained release of therapeutic agent

#447
20140073612
2014-03-13

TRANSDERMAL DELIVERY SYSTEM KIT

#448
20140060525
2014-03-06

Drug condensation aerosols and kits

#449
20140051767
2014-02-20

Parenteral formulations of rasagiline

#450
20140046287
2014-02-13

Microfabricated nanopore device for sustained release of therapeutic agent

#451
20140010876
2014-01-09

PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE

#452
20130323177
2013-12-05

Tumor-targeting gas-generating nanoparticle, method for preparing the same, and tumor-targeting nanoparticle for drug delivery using the same

#453
20130317063
2013-11-28

Oral controlled release pharmaceutical compositions of bepotastine

#454
20130309302
2013-11-21

Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil

#455
20130296833
2013-11-07

Biodegradable osmotic pump implant for drug delivery

#456
20130281969
2013-10-24

Controlled release nanoparticulate matter delivery system

#457
20130276799
2013-10-24

Method and system for drug delivery

#458
20130247376
2013-09-26

Two-piece, internal-channel osmotic delivery system flow modulator

#459
20130245071
2013-09-19

Multiple PPI dosage form

#460
20130211368
2013-08-15

Microfabricated nanopore device for sustained release of therapeutic agent

#461
20130209562
2013-08-15

Methods and devices for providing prolonged drug therapy

#462
20130195934
2013-08-01

Methods and devices for providing prolonged drug therapy

#463
20130165859
2013-06-27

Device, system and methods for the oral delivery of therapeutic compounds

#464
20130156615
2013-06-20

Self contained electroosmotic pump and method of making thereof

#465
20130138089
2013-05-30

Two-piece, internal-channel osmotic delivery system flow modulator

#466
20130129824
2013-05-23

Solid drug tablets for implantable drug delivery devices

#467
20130115249
2013-05-09

Osmotic device containing amantadine and an osmotic salt

#468
20130108693
2013-05-02

Dual controlled release dosage form

#469
20130090633
2013-04-11

OSMOTIC PATCH PUMP

#470
20130090287
2013-04-11

Devices, formulations, and methods for delivery of multiple beneficial agents

#471
20130065885
2013-03-14

ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM

#472
20130052263
2013-02-28

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

#473
20130052237
2013-02-28

Methods of manufacturing viscous liquid pharmaceutical formulations

#474
20130043612
2013-02-21

Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms

#475
20130041353
2013-02-14

Electro-osmotic pumps, systems, methods, and compositions

#476
20130035670
2013-02-07

Solvent/polymer solutions as suspension vehicles

#477
20130035669
2013-02-07

Sustained delivery of an active agent using an implantable system

#478
20130034210
2013-02-07

Solvent/polymer solutions as suspension vehicles

#479
20130032139
2013-02-07

Drug condensation aerosols and kits

#480
20130030417
2013-01-31

Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery

#481
20130022654
2013-01-24

Controlled release pharmaceutical compositions of tapentadol

#482
20130022545
2013-01-24

DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL

#483
20130018299
2013-01-17

Nanoshells on polymers

#484
20130004545
2013-01-03

SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE

#485
20120330282
2012-12-27

Two-piece, internal-channel osmotic delivery system flow modulator

#486
20120330005
2012-12-27

PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE

#487
20120303001
2012-11-29

System and method for correction of intracerebral chemical imbalances

#488
20120301547
2012-11-29

Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof

#489
20120289944
2012-11-15

HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF

#490
20120289943
2012-11-15

OSMOTIC PUMP WITH REMOTELY CONTROLLED OSMOTIC FLOW RATE

#491
20120283275
2012-11-08

METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF BENZISOZAZOLE DERIVATIVES

#492
20120263788
2012-10-18

Controlled release hydrocodone formulations

#493
20120259318
2012-10-11

Solvent/polymer solutions as suspension vehicles

#494
20120253099
2012-10-04

Drug delivery

#495
20120251590
2012-10-04

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#496
20120244222
2012-09-27

OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS

#497
20120239007
2012-09-20

Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners

#498
20120208851
2012-08-16

Colloidal suspensions comprising a therapeutic agent and squalene

#499
20120208773
2012-08-16

PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE

#500
20120197114
2012-08-02

Nanocarriers for imaging and therapy applications

#501
20120195966
2012-08-02

ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR

#502
20120184945
2012-07-19

Two-piece, internal-channel osmotic delivery system flow modulator

#503
20120178771
2012-07-12

Oral Pharmaceutical Compositions of Buprenorphine and Method of Use

#504
20120178687
2012-07-12

Osmotic delivery comprising an insulinotropic peptide and uses thereof

#505
20120171287
2012-07-05

Osmotic pump controlled release tablet and preparation method thereof

#506
20120165361
2012-06-28

DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME

#507
20120165358
2012-06-28

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#508
20120156289
2012-06-21

Biodegradable osmotic pump implant for drug delivery

#509
20120128778
2012-05-24

COMPOSITIONS AND METHODS FOR ONCE-DAILY ADMINISTRATION OF A TRILAYER OSMOTIC TABLET

#510
20120128735
2012-05-24

Methods of treatment using a gastric retained gabapentin dosage

#511
20120128730
2012-05-24

COMPOSITIONS AND METHODS FOR ONCE-DAILY TREATMENT OF OBSESSIVE COMPULSIVE DISORDER WITH ONDANSETRON

#512
20120087978
2012-04-12

DOSAGE FORMS OF APIXABAN

#513
20120083468
2012-04-05

METHOD FOR PREPARING A MEDICAL SOLUTION FOR THE MANUFACTURE OF A MEDICAMENT FOR PERITONEAL DIALYSIS

#514
20120071500
2012-03-22

Macrocyclic lactone compounds and methods for their use

#515
20120070496
2012-03-22

ANTIDEPRESSANT DOSAGE FORM

#516
20120070476
2012-03-22

Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces

#517
20120070465
2012-03-22

PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE

#518
20120065221
2012-03-15

Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

#519
20120064168
2012-03-15

Methods of treatment using a gastric retained gabapentin dosage

#520
20120059257
2012-03-08

Ingestible event markers comprising an ingestible component

#521
20120053451
2012-03-01

Methods and systems for prolonged localization of drug delivery

#522
20120046638
2012-02-23

Method of inducing a CTL response

#523
20120045504
2012-02-23

ORAL DRUG DEVICES AND DRUG FORMULATIONS

#524
20120045485
2012-02-23

Sustained release dosage form

#525
20120034272
2012-02-09

Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic

#526
20120027856
2012-02-02

PHARMACEUTICAL PRODUCT COMPRISING YEAST

#527
20120027823
2012-02-02

Methods of treatment using a gastric retained gabapentin dosage

#528
20120021040
2012-01-26

Therapeutic agent for spinal cord injuries

#529
20120015031
2012-01-19

NOVEL GASTRO-RETENTIVE DOSAGE FORMS

#530
20120015028
2012-01-19

Controlled-Released Osmotic Pump Tablet with Lubricating Layer and the Preparation Thereof

#531
20120009266
2012-01-12

COMPOSITION COMPRISING OCAPERIDONE

#532
20110318392
2011-12-29

Drug coating providing high drug loading and methods for providing the same

#533
20110313009
2011-12-22

NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE

#534
20110312898
2011-12-22

PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER

#535
20110311620
2011-12-22

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

#536
20110308061
2011-12-22

Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles

#537
20110301576
2011-12-08

Two-piece, internal-channel osmotic delivery system flow modulator

#538
20110300217
2011-12-08

HYDROMORPHONE THERAPY

#539
20110293706
2011-12-01

Nanoshells on polymers

#540
20110264077
2011-10-27

Solvent/polymer solutions as suspension vehicles

#541
20110264076
2011-10-27

Polyoxaester suspending vehicles for use with implantable delivery systems

#542
20110262538
2011-10-27

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#543
20110253135
2011-10-20

METAL COORDINATION COMPLEXES OF VOLATILE DRUGS

#544
20110250268
2011-10-13

Compositions and methods for inhibiting gastric acid secretion

#545
20110244042
2011-10-06

Stabilized formulations of CNS compounds

#546
20110244020
2011-10-06

DRUG CONDENSATION AEROSOLS AND KITS

#547
20110236436
2011-09-29

Pharmaceutical composition for modified release

#548
20110230865
2011-09-22

Sustained delivery of an active agent using an implantable system

#549
20110229533
2011-09-22

EXTENDED RELEASE DOSAGE FORM

#550
20110223233
2011-09-15

Microfabricated nanopore device for sustained release of therapeutic agent

#551
20110218601
2011-09-08

Skin patch laminate body

#552
20110208168
2011-08-25

Particle formulations for use in pharmaceutical compositions

#553
20110201926
2011-08-18

LOCAL EMBOLIZATION VIA HEATING OF THERMOSENSITIVE POLYMERS

#554
20110195981
2011-08-11

METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF BENZISOZAZOLE DERIVATIVES

#555
20110195119
2011-08-11

Controlled release metformin formulations

#556
20110195097
2011-08-11

Composition and dosage form comprising a particle formulation and suspending vehicle

#557
20110189279
2011-08-04

PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE PROPERTIES COMPRISING 5-CHLORO-N-(-METHYL)-2-THIOPHENCARBOXAMID

#558
20110189273
2011-08-04

Method of administering amantadine prior to a sleep period

#559
20110184389
2011-07-28

OSMOTIC PUMP APPARATUS AND ASSOCIATED METHODS

#560
20110182947
2011-07-28

Hydrogel-driven drug dosage form

#561
20110171309
2011-07-14

Compositions and Methods for Composite Nanoparticle Hydrogels

#562
20110166554
2011-07-07

Osmotic delivery systems and piston assemblies for use therein

#563
20110159046
2011-06-30

CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE

#564
20110131754
2011-06-09

Process

#565
20110129507
2011-06-02

CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE

#566
20110123612
2011-05-26

PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER

#567
20110111039
2011-05-12

Compositions and methods for inhibiting gastric acid secretion

#568
20110111022
2011-05-12

PHARMACEUTICAL FORMULATION

#569
20110111021
2011-05-12

PHARMACEUTICAL PREPARATION

#570
20110104214
2011-05-05

ONCE-A-DAY OXYCODONE FORMULATIONS

#571
20110104111
2011-05-05

Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles

#572
20110097395
2011-04-28

Oral Pharmaceutical Compositions of Buprenorphine and Method of Use

#573
20110086913
2011-04-14

METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN

#574
20110077258
2011-03-31

Treatment of malaria

#575
20110076317
2011-03-31

Rapid establishment and/or termination of substantial steady-state drug delivery

#576
20110060309
2011-03-10

Implantable device for controlled drug delivery

#577
20110053866
2011-03-03

PHARMACEUTICAL COMPOSITIONS

#578
20110052666
2011-03-03

Compositions, Methods, and Systems for SIRNA Delivery

#579
20110038927
2011-02-17

Controlled release hydrocodone formulations

#580
20110034976
2011-02-10

Drug delivery

#581
20110034498
2011-02-10

DOSING REGIMENS FOR THE TREATMENT OF CANCER

#582
20110027331
2011-02-03

AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION

#583
20110011310
2011-01-20

METHOD OF MANUFACTURING A COMPOSITE BASED ON COMPLEXES OF CONTROLLED STABILITY

#584
20100331770
2010-12-30

Implantable drug delivery devices and methods of making the same

#585
20100330149
2010-12-30

Solid drug tablets for implantable drug delivery devices

#586
20100316708
2010-12-16

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#587
20100297209
2010-11-25

SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES

#588
20100291208
2010-11-18

Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof

#589
20100286600
2010-11-11

TRANSDERMAL PATCH DEVICE

#590
20100260810
2010-10-14

ANTIDEPRESSANT DOSAGE FORM

#591
20100241089
2010-09-23

SKIN PATCH LAMINATE BODY

#592
20100226855
2010-09-09

Rate-Controlled Oral Dosage Formulations

#593
20100222435
2010-09-02

Modified-release formulations of a bupropion salt

#594
20100221322
2010-09-02

Abuse-Resistant Pharmaceutical Dosage Form

#595
20100221293
2010-09-02

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#596
20100221292
2010-09-02

Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent

#597
20100209489
2010-08-19

Formulations of desvenlafaxine

#598
20100203148
2010-08-12

Encapsulation and controlled release of small molecules for intracellular delivery using thermally responsive nanocapsules

#599
20100196425
2010-08-05

OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS

#600
20100185185
2010-07-22

System and method for correction of intracerebral chemical imbalances